Available Until 12/1/2023

COVID-19 Vaccine: Update from the FDA COVID Vaccine Chief

ACPE Activity Number: 0204-0000-20-045-H06-P / 0204-0000-20-045-H06-T
Release Date: December 1, 2020
Expiration Date: December 1, 2023
Activity Type: Knowledge-based  
CE Credits: 1.0 hour, no partial credit
Activity Fee: Members – Free / Non-Member – Free

This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview

Join us for this timely webinar with Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research (CBER) at the FDA. He is leading efforts to make safe, effective, and transparent decisions about COVID-19 vaccine candidates. He will share insights into COVID-19 vaccine clinical trials and the vaccine approval process so that you can make informed decisions for yourself, your patients, and your organizations about the best way to receive, handle, and administer these novel vaccines.


The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Target Audience

This activity was planned to meet the educational needs of pharmacists and pharmacy technicians.

Learning Objectives

  • Explain how vaccines against SARS-CoV-2 are a critical countermeasure to addressing the COVID-19 pandemic
  • List steps of the FDA Center for Biologics Evaluation and Research vaccine approval and authorization process
  • Describe efforts to ensure the quality, safety, and efficacy of COVID-19 vaccine candidates
  • Identify opportunities to ensure successful execution of a mass administration effort of COVID-19 vaccines

Schedule of Activities

  • Introduction and Announcements
  • Presentation
  • Questions, Answers, and Discussion


  • Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research (CBER), FDA
  • Tom Kraus, JD, Vice President of Government Relations, ASHP
  • Anna Legreid Dopp, Pharm.D., Senior Director, Clinical Guidelines and Quality Improvement, ASHP


In accordance with the ACPE's and ACCME's Standards for Commercial Support, anyone in a position to control the content of an educational activity is required to disclose to the accredited provider their relevant financial relationships. In accordance with these Standards, all potential conflicts of interest have been resolved. An individual has a relevant financial relationship if he or she (or spouse/domestic partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the activity content over which the individual has control.

As defined by ACCME, a commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The Standards for Commercial Support do not consider providers of clinical service directly to patients to be commercial interests. The existence or non-existence of relevant financial relationships will be disclosed to the activity audience. All identified conflicts of interest must be resolved prior to the activity.

  • All planners, presenters, reviewers, and ASHP staff report no financial relationships relevant to this activity. 

Methods and CE Requirements

This activity consists of a recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP eLearning Portal. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Claim your CE at http://elearning.ashp.org. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.